SAR442168 (tolebrutinib) is an orally bioavailable, brain-penetrant, selective, small-molecule inhibitor of Bruton's tyrosine ...

New Delhi: The pharmaceutical major Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under the ...

China: A recent case study published in The Open Dentistry Journal sheds light on a dental issue faced by patients with ...

Mumbai: Venus Remedies Limited, a pharmaceutical company specializing in critical care injectables, has announced that its ...

Amid the ongoing controversy on the double shift format for the National Eligibility-Entrance Test for Postgraduate (NEET-PG) ...

A recent study by Yuya Ogino and colleagues created a scoring model for early Crohn's disease (CD) diagnosis based on results ...

USA: A recent study on suspected sepsis in the emergency department (ED) highlighted the overuse of antibiotics. Among 600 ...

USA: Researchers have found in a new study that betamethasone retreatment restores benefits for severe intraventricular ...

Myopia, or nearsightedness, affects two billion people worldwide. Uncorrected myopia can impair vision, disrupting education, ...

The Uttar Pradesh Director General, Medical Education and Training (UPDGME) is going to start the online counselling for the ...

Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report ...

A new study published in the journal of Diabetes Research and Clinical Practice showed that following bariatric surgery, ...